Literature DB >> 18620517

Cholesterol ester transfer protein: a therapeutic target in atherosclerosis?

Ekaterini Vourvouhaki1, George V Dedoussis.   

Abstract

BACKGROUND: CETP has an established role in the transport of cholesterol from the peripheral tissues to the liver for elimination. The fact that CETP was recognized as a target for raising high-density lipoprotein cholesterol (HDL-C) levels has led to research on CETP inhibitors to protect against atherosclerosis.
OBJECTIVE: To review the role of CETP as a pivotal target for atherosclerosis and cardiovascular diseases and the effect of its overexpression or inhibition on lipid metabolism.
METHODS: A review of literature on the role of CETP in cholesterol metabolism and on recent developments on CETP inhibitors. RESULTS/
CONCLUSIONS: Animal and human studies have provided evidence supporting both the pro- and antiatherogenic roles of CETP. Clinical trials with CETP inhibitors remain under serious consideration. Further studies are necessary for understanding of the role of CETP in lipid metabolism and the development of novel therapies involving a combination of strategies for treatment of atherosclerosis and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620517     DOI: 10.1517/14728222.12.8.937

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  2 in total

Review 1.  New horizons for cholesterol ester transfer protein inhibitors.

Authors:  Gregory G Schwartz
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

2.  Integrated probability of coronary heart disease subject to the -308 tumor necrosis factor-alpha SNP: a Bayesian meta-analysis.

Authors:  C Sofia Carvalho
Journal:  PeerJ       Date:  2015-09-15       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.